Share

MYOCET® PROTOCOL (PHASE II) 

Project objectives

Use of non-pegylated liposomal Doxorubicin (Myocet®) as second line in advanced epithelial ovarian cancer. 

Start and end date

2007 - 2011

Project Manager

Prof. Angioli Roberto - Coordinator

Coordinating institution of the project

UCBM
magnifiercrossmenuchevron-downchevron-leftchevron-right